HopeStage
Back to all studies
CompletedNCT02146911

Bupropion or Varenicline With Email Support for Smoking Cessation

About this titleRead the official source — NCT02146911
Medication studyAges 19–90CanadaAddiction
The study in practice

Understand this study

Who was this study for?

Listed age limits: 19 years to 90 years.

Listed locations
TorontoSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: May 1, 2014
Recruitment status
Completed
Enrollment listed in the registry
968
Sponsor
Centre for Addiction and Mental Health
Sponsor type
Hospital / academic medical center
Study type
Drug
Intervention type
Behavioural, Drug
Locations
Canada
Age range
From 19 Years to 90 Years
Official registry ID
NCT02146911
Official title
Show the full official title

Evaluating the Real-world Effectiveness of Varenicline and Bupropion for Long-term Smoking Cessation

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Toronto

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Centre for Addiction and Mental Health, a hospital or academic medical center.

Did this study involve medication?

Yes. The study involved medication, including Bupropion and Varenicline.

Who was this study for?

Listed age limits: 19 years to 90 years.

Want to explore more studies?

Explore studies